Redsense presents on Aktiedagen Digitalt

Redsense Medical AB will participate in the virtual investor meet Aktiedagen Digitalt. Patrik Byhmer, CEO, will present the company and its operations at 10:30 a.m. on Monday, September 21, 2020. The presentation will be held in Swedish.

To view the list of speakers and find more information about the event, please visit https://www.aktiespararna.se/aktiviteter/aktiedagen-digitalt-21-september-2020.

“We welcome anyone interested in the company, our technology and our development strategy to attend this event. Redsense Medical is in a very exciting phase at the moment, with a resilient performance over the course of the pandemic, booming sales driven by U.S. renal care initatives, and a recent turnaround to positive quarterly results. Our activities comprise a healthy and dynamic combination of well-established life-saving products and cutting-edge development projects with considerable promise  for the vast wound-care market,” says Patrik Byhmer, CEO of Redsense Medical AB.

Aktiedagen Digitalt is held as a purely digital event and is free to attend. Company representatives will be available to answer questions after their presentations, and you are welcome to submit questions in advance. Live and on demand streams from the presentations will be available at https://www.aktiespararna.se/tv/live.

For more information, please contact:

Patrik Byhmer, CEO Redsense Medical AB (publ)

Phone: +46 35 10 60 30

info@redsensemedical.com 

www.redsensemedical.com

ABOUT REDSENSE MEDICAL

Redsense Medical is a corporate group with operations mainly in Europe and the United States. The company has developed the Redsense System, an innovationused for monitoring and alarm in the case of blood leakage in connection with a hemodialysis treatment. Redsense Medical solves one of the most serious remaining safety problems within hemodialysis – to quickly detect Venous Needle Dislodgement and catheter leakage to minimize blood leakage. The system consists of a patented fiber optic sensor, designed for either venous needle or central venous catheter, which is connected to an alarm unit. From the very start, the development of the company's technology has been based on the demands and safety requirements of healthcare providers in the dialysis sector.     

Subscribe